7:22 PM
 | 
Mar 04, 2009
 |  BC Extra  |  Company News

Allergy seeking German approval of Pollinex Quattro Grass

Allergy Therapeutics (LSE:AGY) submitted an application in Germany seeking approval of Pollinex...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >